Annual EBITDA
-$165.43 M
+$44.12 M+21.06%
December 31, 2023
Summary
- As of February 7, 2025, CNTA annual EBITDA is -$165.43 million, with the most recent change of +$44.12 million (+21.06%) on December 31, 2023.
- During the last 3 years, CNTA annual EBITDA has fallen by -$155.14 million (-1508.41%).
- CNTA annual EBITDA is now -3250.72% below its all-time high of -$4.94 million, reached on December 31, 2019.
Performance
CNTA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$39.16 M
+$1.19 M+2.94%
September 30, 2024
Summary
- As of February 7, 2025, CNTA quarterly EBITDA is -$39.16 million, with the most recent change of +$1.19 million (+2.94%) on September 30, 2024.
- Over the past year, CNTA quarterly EBITDA has dropped by -$470.00 thousand (-1.21%).
- CNTA quarterly EBITDA is now -186.58% below its all-time high of $45.23 million, reached on December 1, 2020.
Performance
CNTA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$147.19 M
-$470.00 K-0.32%
September 30, 2024
Summary
- As of February 7, 2025, CNTA TTM EBITDA is -$147.19 million, with the most recent change of -$470.00 thousand (-0.32%) on September 30, 2024.
- Over the past year, CNTA TTM EBITDA has increased by +$26.96 million (+15.48%).
- CNTA TTM EBITDA is now -275.29% below its all-time high of $83.97 million, reached on March 31, 2021.
Performance
CNTA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CNTA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.1% | -1.2% | +15.5% |
| 3 y3 years | -1508.4% | - | - |
| 5 y5 years | - | - | - |
CNTA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +21.1% | -19.1% | +37.8% | -9.4% | +29.8% |
| 5 y | 5-year | -3250.7% | +21.1% | -186.6% | +37.8% | -275.3% | +29.8% |
| alltime | all time | -3250.7% | +21.1% | -186.6% | +37.8% | -275.3% | +29.8% |
Centessa Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$39.16 M(-2.9%) | -$147.19 M(+0.3%) |
| Jun 2024 | - | -$40.35 M(+16.0%) | -$146.72 M(-3.9%) |
| Mar 2024 | - | -$34.80 M(+5.8%) | -$152.62 M(-7.7%) |
| Dec 2023 | -$165.43 M(-21.1%) | -$32.88 M(-15.0%) | -$165.43 M(-5.0%) |
| Sep 2023 | - | -$38.70 M(-16.3%) | -$174.15 M(-7.1%) |
| Jun 2023 | - | -$46.25 M(-2.8%) | -$187.51 M(-8.2%) |
| Mar 2023 | - | -$47.60 M(+14.4%) | -$204.26 M(-2.5%) |
| Dec 2022 | -$209.55 M | -$41.60 M(-20.1%) | -$209.54 M(+24.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$52.06 M(-17.4%) | -$167.95 M(+7.6%) |
| Jun 2022 | - | -$63.00 M(+19.1%) | -$156.04 M(+16.0%) |
| Mar 2022 | - | -$52.89 M(+31.7%) | -$134.50 M(-5799.0%) |
| Sep 2021 | - | -$40.16 M(-3.1%) | $2.36 M(-94.4%) |
| Jun 2021 | - | -$41.45 M(-207.0%) | $42.52 M(-49.4%) |
| Mar 2021 | - | $38.73 M(-14.4%) | $83.97 M(+85.6%) |
| Dec 2020 | -$10.29 M(+108.3%) | - | - |
| Dec 2020 | - | $45.23 M | $45.23 M |
| Dec 2019 | -$4.94 M | - | - |
FAQ
- What is Centessa Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual EBITDA year-on-year change?
- What is Centessa Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Centessa Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals TTM EBITDA year-on-year change?
What is Centessa Pharmaceuticals annual EBITDA?
The current annual EBITDA of CNTA is -$165.43 M
What is the all time high annual EBITDA for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual EBITDA is -$4.94 M
What is Centessa Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, CNTA annual EBITDA has changed by +$44.12 M (+21.06%)
What is Centessa Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of CNTA is -$39.16 M
What is the all time high quarterly EBITDA for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly EBITDA is $45.23 M
What is Centessa Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, CNTA quarterly EBITDA has changed by -$470.00 K (-1.21%)
What is Centessa Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of CNTA is -$147.19 M
What is the all time high TTM EBITDA for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high TTM EBITDA is $83.97 M
What is Centessa Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, CNTA TTM EBITDA has changed by +$26.96 M (+15.48%)